「by」の検索結果
77件：16～20件目を表示
-
Management Policy | About Senju | SENJU Pharmaceutical
vision, and ideal employee image) into a concept called the "Senju Sense" that is shared by all Senju employees in the organization. To enhance unity and understanding among our employees, ...
http://www.senju.co.jp/english/about/philosophy.html -
that it has received approval for the marketing of “Mytear Lumify” (OTC drug requiring instruction by pharmacist, hereinafter this "Product") from Ministry of Health, Labour and Welfare. Th...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
ular hypertension. Pharmaceutical information activities for this product will be conducted jointly by Senju Pharmaceutical Co., Ltd. (manufacturer and distributor) and Otsuka Pharmaceutical Co., Ltd....
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
ical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of RET-700 in Japan, effective immediately (medical device a...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
tes Completed NCT04139122 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patie...
http://www.senju.co.jp/english/rd/trial.html